Thiazole/Thiadiazole/Benzothiazole Based Thiazolidin-4-One Derivatives as Potential Inhibitors of Main Protease of SARS-CoV-2

Thiazole/Thiadiazole/Benzothiazole Based Thiazolidin-4-One Derivatives as Potential Inhibitors of Main Protease of SARS-CoV-2

Since the time of its appearance until present, COVID-19 has spread worldwide, with over 71 million confirmed cases and over 1.6 million deaths reported by the World Health Organization (WHO). In addition to the fact that cases of COVID-19 are increasing worldwide, the Delta and Omicron variants hav...

Full description

Bibliographic Details
Main Authors:	Anthi Petrou, Panagiotis Zagaliotis, Nikoleta F. Theodoroula, George A. Mystridis, Ioannis S. Vizirianakis, Thomas J. Walsh, Athina Geronikaki
Format:	Article
Language:	English
Published:	MDPI AG 2022-03-01
Series:	Molecules
Subjects:	SARS-CoV-2 main protease inhibitors COVID-19 docking studies in vitro experiment
Online Access:	https://www.mdpi.com/1420-3049/27/7/2180

Similar Items

Developing New Treatments for COVID-19 through Dual-Action Antiviral/Anti-Inflammatory Small Molecules and Physiologically Based Pharmacokinetic Modeling
by: Panagiotis Zagaliotis, et al.
Published: (2022-07-01)

Thiazolidin-4-Ones as Potential Antimicrobial Agents: Experimental and In Silico Evaluation
by: Christophe Tratrat, et al.
Published: (2022-03-01)

Novel Thiazolidin-4-ones as Potential Non-Nucleoside Inhibitors of HIV-1 Reverse Transcriptase
by: Anthi Petrou, et al.
Published: (2019-10-01)

In Silico Evaluation of the Effectivity of Approved Protease Inhibitors against the Main Protease of the Novel SARS-CoV-2 Virus
by: Phaedra Eleftheriou, et al.
Published: (2020-05-01)

Structural Basis for the Inhibition of Coronaviral Main Proteases by a Benzothiazole-Based Inhibitor
by: Xiaohui Hu, et al.
Published: (2022-09-01)

4-(Indol-3-yl)thiazole-2-amines and 4-ιndol-3-yl)thiazole Acylamines as Νovel Antimicrobial Agents: Synthesis, In Silico and In Vitro Evaluation
by: Sergei Simakov, et al.
Published: (2021-10-01)

Statins and the COVID-19 main protease: in silico evidence on direct interaction
by: Željko Reiner, et al.
Published: (2020-04-01)

Evaluation of therapeutic potentials of some bioactive compounds in selected African plants targeting main protease (Mpro) in SARS-CoV-2: a molecular docking study
by: Ishola Abeeb Akinwumi, et al.
Published: (2023-12-01)

Thiazole Ring—A Biologically Active Scaffold
by: Anthi Petrou, et al.
Published: (2021-05-01)

Molecular Docking of Novel 5-O-benzoylpinostrobin Derivatives as SARS-CoV-2 Main Protease Inhibitors
by: Mohammad Rizki Fadhil Pratama, et al.
Published: (2020-11-01)

Experimental and In Silico Evaluation of New Heteroaryl Benzothiazole Derivatives as Antimicrobial Agents
by: Alexander Zubenko, et al.
Published: (2022-11-01)

Support Vector Machine as a Supervised Learning for the Prioritization of Novel Potential SARS-CoV-2 Main Protease Inhibitors
by: Nedra Mekni, et al.
Published: (2021-07-01)

Crystal structures of main proteases of SARS-CoV-2 variants bound to a benzothiazole-based inhibitor
by: Luo Jiqing, et al.
Published: (2023-06-01)

Triazolo Based-Thiadiazole Derivatives. Synthesis, Biological Evaluation and Molecular Docking Studies
by: Charalampos Kamoutsis, et al.
Published: (2021-07-01)

Comparison of COVID-19 Virus Main Protease Inhibition Activities of Phenolic Acids By Molecular Docking
by: Razie Sabet, et al.
Published: (2021-06-01)

Computational Screening of Phenylamino-Phenoxy-Quinoline Derivatives against the Main Protease of SARS-CoV-2 Using Molecular Docking and the ONIOM Method
by: Suwicha Patnin, et al.
Published: (2022-03-01)

Comprehensive Understanding of the Kinetic Behaviors of Main Protease from SARS-CoV-2 and SARS-CoV: New Data and Comparison to Published Parameters
by: Fangya Li, et al.
Published: (2023-06-01)

Multi-Step In Silico Discovery of Natural Drugs against COVID-19 Targeting Main Protease
by: Eslam B. Elkaeed, et al.
Published: (2022-06-01)

Synthesis and Antimicrobial Activity of New Heteroaryl(aryl) Thiazole Derivatives Molecular Docking Studies
by: Victor Kartsev, et al.
Published: (2022-09-01)

Towards potential inhibitors of COVID-19 main protease Mpro by virtual screening and molecular docking study
by: Moujane Soumia, et al.
Published: (2020-01-01)

Computational Simulation of HIV Protease Inhibitors to the Main Protease (Mpro) of SARS-CoV-2: Implications for COVID-19 Drugs Design
by: Wei Yu, et al.
Published: (2021-12-01)

A Multistage In Silico Study of Natural Potential Inhibitors Targeting SARS-CoV-2 Main Protease
by: Eslam B. Elkaeed, et al.
Published: (2022-07-01)

In Silico Studies of Some Isoflavonoids as Potential Candidates against COVID-19 Targeting Human ACE2 (hACE2) and Viral Main Protease (M<sup>pro</sup>)
by: Mohamed S. Alesawy, et al.
Published: (2021-05-01)

POTENSI DAUN TEH HIJAU (Camellia sinensis) SEBAGAI INHIBITOR MAIN PROTEASE (Mpro) COVID-19: SEBUAH STUDI MOLECULAR DOCKINGPOTENSI DAUN TEH HIJAU (Camellia sinensis) SEBAGAI INHIBITOR MAIN PROTEASE (Mpro) COVID-19: SEBUAH STUDI MOLECULAR DOCKING
by: Haidar Ali Hamzah, et al.
Published: (2022-10-01)

A Computational Approach to Explore the Interaction of Semisynthetic Nitrogenous Heterocyclic Compounds with the SARS-CoV-2 Main Protease
by: Alejandro Llanes, et al.
Published: (2020-12-01)

In Silico Identification and Validation of Organic Triazole Based Ligands as Potential Inhibitory Drug Compounds of SARS-CoV-2 Main Protease
by: Vishma Pratap Sur, et al.
Published: (2021-10-01)

Computer-Aided Screening for Potential Coronavirus 3-Chymotrypsin-like Protease (3CLpro) Inhibitory Peptides from Putative Hemp Seed Trypsinized Peptidome
by: Kansate Prasertsuk, et al.
Published: (2022-12-01)

Search of Novel Small Molecule Inhibitors for the Main Protease of SARS-CoV-2
by: Wenfa Zhang, et al.
Published: (2023-02-01)

Promising inhibitors against main protease of SARS CoV-2 from medicinal plants: In silico identification
by: EBENEZER OLUWAKEMI, et al.
Published: (2022-06-01)

In Silico Insights into the SARS CoV-2 Main Protease Suggest NADH Endogenous Defences in the Control of the Pandemic Coronavirus Infection
by: Annamaria Martorana, et al.
Published: (2020-07-01)

In silico exploration of novel protease inhibitors against coronavirus 2019 (COVID-19)
by: Elham Aghaee, et al.
Published: (2021-01-01)

Inhibitory activity of FDA-approved drugs cetilistat, abiraterone, diiodohydroxyquinoline, bexarotene, remdesivir, and hydroxychloroquine on COVID-19 main protease and human ACE2 receptor: A comparative in silico approach
by: Nahid Shahabadi, et al.
Published: (2021-01-01)

Identification of potential COVID-19 main protease inhibitors using structure-based pharmacophore approach, molecular docking and repurposing studies
by: Daoud Safa, et al.
Published: (2021-06-01)

POTENSI DAUN TEH HIJAU (Camellia sinensis) SEBAGAI INHIBITOR MAIN PROTEASE (Mpro) COVID-19: SEBUAH STUDI MOLECULAR DOCKING
by: Haidar Ali Hamzah, et al.
Published: (2022-10-01)

Syzygium aromaticum as a possible source of SARS-CoV-2 main protease inhibitors: Evidence from a computational investigation
by: Md. Chayan Ali, et al.
Published: (2022-04-01)

Identification of a novel inhibitor of SARS-CoV-2 3CL-PRO through virtual screening and molecular dynamics simulation
by: Asim Kumar Bepari, et al.
Published: (2021-04-01)

Recognition of Natural Products as Potential Inhibitors of COVID-19 Main Protease (Mpro): In-Silico Evidences
by: Rohan R. Narkhede, et al.
Published: (2020-06-01)

The coronavirus disease 2019 main protease inhibitor from Andrographis paniculata (Burm.f) Ness
by: Sukardiman, et al.
Published: (2020-01-01)

Design of Potent Inhibitors Targeting the Main Protease of SARS-CoV-2 Using QSAR Modeling, Molecular Docking, and Molecular Dynamics Simulations
by: Mehdi Oubahmane, et al.
Published: (2023-04-01)

Therapeutic capability of five active compounds in typical African medicinal plants against main proteases of SARS-CoV-2 by computational approach
by: Oluwasayo Peter Abodunrin, et al.
Published: (2022-01-01)